CINCINNATI CHILDRENS HOSP MED CTR
The Impact of SLC26A9 on Response to CFTR Correction
The Impact of SLC26A9 on Response to CFTR Correction is a funding opportunity from CINCINNATI CHILDRENS HOSP MED CTR, up to 717742, closing May 31, 2030.
May 31, 2030
(1400d left)Overview
PROJECT ABSTRACT / SUMMARY Although CFTR modulator therapies have improved respiratory outcomes for the Cystic Fibrosis (CF) population, the benefit to individual patients can vary widely. In “real world” studies of modulator therapies, patients continue to experience lung function decline, and as many as 1 in 5…